Sachiyo Minegishi

Chief Financial Officer

Sachiyo Minegishi is the Chief Financial Officer at Kriya. Prior to Kriya, Ms. Minegishi was Chief Operating Officer at Rectify Phar­ma­ceu­ti­cals and Chief Financial Officer at Akouos (acquired by Eli Lilly), and Product Lead for a portfolio of gene therapies for Sickle Cell Disease at bluebird bio. Earlier in her career, Ms. Minegishi held leadership roles at Aegerion, Human Genome Sciences, Genzyme and Amgen, after beginning her career in investment banking at Merrill Lynch. Ms. Minegishi earned a BS in Chemical Engineering and Economics from the Mass­a­chu­setts Institute of Technology and an MBA from the Wharton School of the University of Pennsylvania.